Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

This week, Johnson & Johnson JNJ began the third-quarter earnings season for the drug and biotech sector. The FDA granted ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

Deal volumes for pharmaceutical deals were lower in 2023 than they were 10 years ago and have been lower, on average, than ...

The underlying issue for pharma companies using AI lies in the quality of the inputs and how AI models are used.

Astellas Pharma's drug Vyloy was approved for treatment of advanced gastric and gastroesophageal junction cancer by the Food and Drug Administration.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to ...

The evolution of Pharma 4.0 integrates advanced technologies, transforming drug development and manufacturing with improved ...

Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial ...

Chief Minister Mohan Yadav said that Madhya Pradesh will prepare an attractive Pharma policy to attract investment in the ...